Assembly and localization of Toll-like receptor signalling complexes

Signal transduction by the Toll-like receptors (TLRs) is central to host defence against many pathogenic microorganisms and also underlies a large burden of human disease. Thus, the mechanisms and regulation of signalling by TLRs are of considerable interest. In this Review, we discuss the molecular basis for the recognition of pathogen-associated molecular patterns, the nature of the protein complexes that mediate signalling, and the way in which signals are regulated and integrated at the level of allosteric assembly, post-translational modification and subcellular trafficking of the components of the signalling complexes. These fundamental molecular mechanisms determine whether the signalling output leads to a protective immune response or to serious pathologies such as sepsis. A detailed understanding of these processes at the molecular level provides a rational framework for the development of new drugs that can specifically target pathological rather than protective signalling in inflammatory and autoimmune disease.

[1]  N. Coussens,et al.  Isolation of an endotoxin–MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Giorgio Sirugo,et al.  A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis , 2007, Nature Genetics.

[3]  N. Gay,et al.  Structure and function of Toll receptors and their ligands. , 2007, Annual review of biochemistry.

[4]  S. Paik,et al.  Crystal Structure of the TLR1-TLR2 Heterodimer Induced by Binding of a Tri-Acylated Lipopeptide , 2007, Cell.

[5]  S. Hatakeyama,et al.  Direct binding of TRAF2 and TRAF6 to TICAM-1/TRIF adaptor participates in activation of the Toll-like receptor 3/4 pathway. , 2010, Molecular immunology.

[6]  Takashi Saito,et al.  T-Cell Receptor Microclusters Critical for T-Cell Activation Are Formed Independently of Lipid Raft Clustering , 2010, Molecular and Cellular Biology.

[7]  M. Shirakawa,et al.  Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling , 2009, Proceedings of the National Academy of Sciences.

[8]  Thomas Miethke,et al.  Crystal Structures of the Toll/Interleukin-1 Receptor (TIR) Domains from the Brucella Protein TcpB and Host Adaptor TIRAP Reveal Mechanisms of Molecular Mimicry* , 2013, The Journal of Biological Chemistry.

[9]  F. Martinon,et al.  RIP1 is an essential mediator of Toll-like receptor 3–induced NF-κB activation , 2004, Nature Immunology.

[10]  J. Lippincott-Schwartz,et al.  Imaging Intracellular Fluorescent Proteins at Nanometer Resolution , 2006, Science.

[11]  Hiroyuki Oshiumi,et al.  Spatiotemporal Mobilization of Toll/IL-1 Receptor Domain-Containing Adaptor Molecule-1 in Response to dsRNA1 , 2007, The Journal of Immunology.

[12]  Takuma Shibata,et al.  Structural Reorganization of the Toll-Like Receptor 8 Dimer Induced by Agonistic Ligands , 2013, Science.

[13]  K. Takatsu,et al.  A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is required for TLR-dependent immune responses , 2007, The Journal of experimental medicine.

[14]  Yuqiong Liang,et al.  Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3–mediated pathway , 2011, Proceedings of the National Academy of Sciences.

[15]  A. Smahi,et al.  TLR3 Deficiency in Patients with Herpes Simplex Encephalitis , 2007, Science.

[16]  R. Jerala,et al.  The Ectodomain of the Toll-like Receptor 4 Prevents Constitutive Receptor Activation* , 2011, The Journal of Biological Chemistry.

[17]  Shizuo Akira,et al.  Toll/IL-1 Receptor Domain-Containing Adaptor Inducing IFN-β (TRIF) Associates with TNF Receptor-Associated Factor 6 and TANK-Binding Kinase 1, and Activates Two Distinct Transcription Factors, NF-κB and IFN-Regulatory Factor-3, in the Toll-Like Receptor Signaling 1 , 2003, The Journal of Immunology.

[18]  R. Schekman,et al.  UNC93B1 mediates differential trafficking of endosomal TLRs , 2013, eLife.

[19]  M. Gangloff Different dimerisation mode for TLR4 upon endosomal acidification? , 2012, Trends in biochemical sciences.

[20]  B. Gérard,et al.  TLR9 Activation Induces Normal Neutrophil Responses in a Child with IRAK-4 Deficiency: Involvement of the Direct PI3K Pathway , 2007, The Journal of Immunology.

[21]  Hayyoung Lee,et al.  The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex , 2009, Nature.

[22]  B. Monks,et al.  Ligand-induced conformational changes allosterically activate Toll-like receptor 9 , 2007, Nature Immunology.

[23]  F. Martinon,et al.  MyD88, an Adapter Protein Involved in Interleukin-1 Signaling* , 1998, The Journal of Biological Chemistry.

[24]  Sarah E. Ewald,et al.  The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor , 2008, Nature.

[25]  D. Standley,et al.  Structures and interface mapping of the TIR domain-containing adaptor molecules involved in interferon signaling , 2013, Proceedings of the National Academy of Sciences.

[26]  S. Akira,et al.  The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[27]  B. Seed,et al.  Endoplasmic reticulum chaperone gp96 is required for innate immunity but not cell viability , 2001, Nature Cell Biology.

[28]  P. Rod Dunbar,et al.  Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens , 2010, The Journal of experimental medicine.

[29]  I. Wilson,et al.  Structural Basis of TLR5-Flagellin Recognition and Signaling , 2012, Science.

[30]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[31]  J. Miyoshi,et al.  Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells , 2007, Proceedings of the National Academy of Sciences.

[32]  G. Hartmann,et al.  Toll-like receptors (TLRs) and innate immunity , 2008 .

[33]  N. Gay,et al.  Conserved Features in the Extracellular Domain of Human Toll-like Receptor 8 Are Essential for pH-dependent Signaling* , 2006, Journal of Biological Chemistry.

[34]  S. Horvat,et al.  The Role of Intermediary Domain of MyD88 in Cell Activation and Therapeutic Inhibition of TLRs , 2011, The Journal of Immunology.

[35]  M. Horiuchi,et al.  A Molecular Mechanism for Toll-IL-1 Receptor Domain-containing Adaptor Molecule-1-mediated IRF-3 Activation* , 2010, The Journal of Biological Chemistry.

[36]  A. Bowie,et al.  The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling , 2007, Nature Reviews Immunology.

[37]  S. Akira,et al.  Essential role of MD-2 in LPS responsiveness and TLR4 distribution , 2002, Nature Immunology.

[38]  B. Williams,et al.  Rational design of immunostimulatory siRNAs. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[39]  Michael C. Ostrowski,et al.  Free Cholesterol Accumulation in Macrophage Membranes Activates Toll-Like Receptors and p38 Mitogen-Activated Protein Kinase and Induces Cathepsin K , 2009, Circulation research.

[40]  S. Grinstein,et al.  The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9 , 2006, Nature Immunology.

[41]  M. Sweet,et al.  The TLR signalling adaptor TRIF/TICAM-1 has an N-terminal helical domain with structural similarity to IFIT proteins. , 2013, Acta crystallographica. Section D, Biological crystallography.

[42]  R. Ebright,et al.  Dynamically driven protein allostery , 2006, Nature Structural &Molecular Biology.

[43]  M. Fessler,et al.  Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol[S] , 2010, Journal of Lipid Research.

[44]  S. Paik,et al.  Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. , 2009, Immunity.

[45]  N. Harris,et al.  MYD88 L265P somatic mutation in Waldenström's macroglobulinemia. , 2012, The New England journal of medicine.

[46]  N. Gay,et al.  Structure of toll-like receptors. , 2008, Handbook of experimental pharmacology.

[47]  C. Brooks,et al.  Characterizing the protonation state of cytosine in transient G·C Hoogsteen base pairs in duplex DNA. , 2013, Journal of the American Chemical Society.

[48]  N. Gay,et al.  Toll-like receptors as molecular switches , 2006, Nature Reviews Immunology.

[49]  Sarah E. Ewald,et al.  Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase , 2011, The Journal of experimental medicine.

[50]  N. Gay,et al.  Assembly of Oligomeric Death Domain Complexes during Toll Receptor Signaling* , 2008, Journal of Biological Chemistry.

[51]  J. Casanova,et al.  Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. , 2010, Immunity.

[52]  N. Gay,et al.  Cytokine Spätzle binds to the Drosophila immunoreceptor Toll with a neurotrophin-like specificity and couples receptor activation , 2013, Proceedings of the National Academy of Sciences.

[53]  R. Ulevitch,et al.  MD-2 and TLR4 N-Linked Glycosylations Are Important for a Functional Lipopolysaccharide Receptor* , 2002, The Journal of Biological Chemistry.

[54]  Hao Wu,et al.  Helical assembly in the death domain (DD) superfamily. , 2012, Current opinion in structural biology.

[55]  P. Nordlund,et al.  The Crystal Structure of the Human Toll-like Receptor 10 Cytoplasmic Domain Reveals a Putative Signaling Dimer* , 2008, Journal of Biological Chemistry.

[56]  I. Wilson,et al.  Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[57]  K. Burns,et al.  Inhibition of Interleukin 1 Receptor/Toll-like Receptor Signaling through the Alternatively Spliced, Short Form of MyD88 Is Due to Its Failure to Recruit IRAK-4 , 2003, The Journal of experimental medicine.

[58]  R. Flavell,et al.  Toll-like receptor 3 promotes cross-priming to virus-infected cells , 2005, Nature.

[59]  D. Davies,et al.  Structural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA , 2008, Science.

[60]  M. Fenton,et al.  Cutting Edge: Differential Inhibition of TLR Signaling Pathways by Cell-Permeable Peptides Representing BB Loops of TLRs1 , 2007, The Journal of Immunology.

[61]  J. Metzger,et al.  Toll‐like receptor 9 binds single‐stranded CpG‐DNA in a sequence‐ and pH‐dependent manner , 2004, European journal of immunology.

[62]  D. V. Von Hoff,et al.  A Phase I Dose-Finding Study of the Novel Toll-like Receptor 8 Agonist VTX-2337 in Adult Subjects with Advanced Solid Tumors or Lymphoma , 2014, Clinical Cancer Research.

[63]  Z. Zhou,et al.  Lateral clustering of TLR3:dsRNA signaling units revealed by TLR3ecd:3Fabs quaternary structure. , 2012, Journal of molecular biology.

[64]  C. Janeway Approaching the asymptote? Evolution and revolution in immunology. , 1989, Cold Spring Harbor symposia on quantitative biology.

[65]  L. Tong,et al.  Structural basis for signal transduction by the Toll/interleukin-1 receptor domains , 2000, Nature.

[66]  H. Ploegh,et al.  Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9 , 2008, Nature Immunology.

[67]  M. Shirakawa,et al.  Functional assessment of the mutational effects of human IRAK4 and MyD88 genes. , 2014, Molecular immunology.

[68]  Y. Lo,et al.  Helical assembly in the MyD88:IRAK4:IRAK2 complex in TLR/IL-1R signaling , 2010, Nature.

[69]  J. Qin,et al.  IRAK‐M mediates Toll‐like receptor/IL‐1R‐induced NFκB activation and cytokine production , 2013, The EMBO journal.

[70]  T. Mizutani,et al.  A Protein Associated with Toll-Like Receptor 4 (PRAT4A) Regulates Cell Surface Expression of TLR41 , 2006, The Journal of Immunology.

[71]  E. Beutler,et al.  Synergy between TLR2 and TLR4: a safety mechanism. , 2001, Blood cells, molecules & diseases.

[72]  M. Fessler,et al.  Intracellular Lipid Flux and Membrane Microdomains as Organizing Principles in Inflammatory Cell Signaling , 2011, The Journal of Immunology.

[73]  J. Inoue,et al.  Cutting Edge: TNFR-Associated Factor (TRAF) 6 Is Essential for MyD88-Dependent Pathway but Not Toll/IL-1 Receptor Domain-Containing Adaptor-Inducing IFN-β (TRIF)-Dependent Pathway in TLR Signaling1 , 2004, Journal of Immunology.

[74]  L. Pike,et al.  Cholesterol levels modulate EGF receptor-mediated signaling by altering receptor function and trafficking. , 2002, Biochemistry.

[75]  D. Chaussabel,et al.  Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency. , 2011, The Journal of clinical investigation.

[76]  Michael D. Mason,et al.  Ultra-high resolution imaging by fluorescence photoactivation localization microscopy. , 2006, Biophysical journal.

[77]  Yoshinori Nagai,et al.  MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4 , 1999, The Journal of experimental medicine.

[78]  S. Sprang,et al.  Three-Dimensional Structure of a Complex between the Death Domains of Pelle and Tube , 1999, Cell.

[79]  D. Davies,et al.  The TLR3 signaling complex forms by cooperative receptor dimerization , 2008, Proceedings of the National Academy of Sciences.

[80]  T. Nishiya,et al.  Distinct roles of TIR and non‐TIR regions in the subcellular localization and signaling properties of MyD88 , 2007, FEBS letters.

[81]  Inhibitors of TLR8 Reduce TNF Production from Human Rheumatoid Synovial Membrane Cultures1 , 2008, The Journal of Immunology.

[82]  A. Bowie,et al.  The interleukin-1 receptor-associated kinases: critical regulators of innate immune signalling. , 2010, Biochemical pharmacology.

[83]  F. DiMaio,et al.  Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals the molecular basis for signal transduction and disease protection , 2011, Proceedings of the National Academy of Sciences.

[84]  Hayyoung Lee,et al.  Crystal Structure of the TLR4-MD-2 Complex with Bound Endotoxin Antagonist Eritoran , 2007, Cell.

[85]  N. Gay,et al.  Trif-related adapter molecule is phosphorylated by PKC{epsilon} during Toll-like receptor 4 signaling. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[86]  N. Gay,et al.  Trif-related adapter molecule is phosphorylated by PKC during Toll-like receptor 4 signaling , 2006 .

[87]  Wei Zhang,et al.  The crystal structure of the BAR domain from human Bin1/amphiphysin II and its implications for molecular recognition. , 2006, Biochemistry.

[88]  E. Sundberg,et al.  Recruitment of TLR adapter TRIF to TLR4 signaling complex is mediated by the second helical region of TRIF TIR domain , 2013, Proceedings of the National Academy of Sciences.

[89]  E. Ikonen,et al.  Functional rafts in cell membranes , 1997, Nature.

[90]  E. Latz,et al.  The Rab11a GTPase controls Toll-like receptor 4-induced activation of interferon regulatory factor-3 on phagosomes. , 2010, Immunity.

[91]  J. Casanova,et al.  Herpes Simplex Virus Encephalitis in Human UNC-93B Deficiency , 2006, Science.

[92]  J. Banchereau,et al.  Pyogenic Bacterial Infections in Humans with MyD88 Deficiency , 2003, Science.

[93]  N. Gay,et al.  The COP II adaptor protein TMED7 is required to initiate and mediate the delivery of TLR4 to the plasma membrane , 2014, Science Signaling.

[94]  E. Latz,et al.  Endocytic pathways regulate Toll‐like receptor 4 signaling and link innate and adaptive immunity , 2006, The EMBO journal.

[95]  A. Iwasaki,et al.  A Promiscuous Lipid-Binding Protein Diversifies the Subcellular Sites of Toll-like Receptor Signal Transduction , 2014, Cell.

[96]  J. Liu,et al.  Association of TIRAP (MAL) gene polymorhisms with susceptibility to tuberculosis in a Chinese population. , 2011, Genetics and molecular research : GMR.

[97]  D. Shaw,et al.  Conformational Coupling across the Plasma Membrane in Activation of the EGF Receptor , 2013, Cell.

[98]  C. Robinson,et al.  An Oligomeric Signaling Platform Formed by the Toll-like Receptor Signal Transducers MyD88 and IRAK-4* , 2009, The Journal of Biological Chemistry.

[99]  J. Lakowicz,et al.  Targeting TLR4 Signaling by TLR4 Toll/IL-1 Receptor Domain-Derived Decoy Peptides: Identification of the TLR4 Toll/IL-1 Receptor Domain Dimerization Interface , 2011, The Journal of Immunology.

[100]  Y. Satow,et al.  Crystal Structures of Human MD-2 and Its Complex with Antiendotoxic Lipid IVa , 2007, Science.

[101]  Xuetao Cao,et al.  Ras-related protein Rab10 facilitates TLR4 signaling by promoting replenishment of TLR4 onto the plasma membrane , 2010, Proceedings of the National Academy of Sciences.

[102]  Joseph M. Connors,et al.  Oncogenically active MYD88 mutations in human lymphoma , 2011, Nature.

[103]  N. Gay,et al.  What the Myddosome structure tells us about the initiation of innate immunity. , 2011, Trends in immunology.

[104]  R. Medzhitov,et al.  Phosphoinositide-Mediated Adaptor Recruitment Controls Toll-like Receptor Signaling , 2006, Cell.

[105]  S. Akira,et al.  Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway , 2002, Nature Immunology.

[106]  N. Gay,et al.  An Alanine-to-Proline Mutation in the BB-Loop of TLR3 Toll/IL-1R Domain Switches Signalling Adaptor Specificity from TRIF to MyD88 , 2013, The Journal of Immunology.

[107]  N. Gay,et al.  A Dimer of the Toll-Like Receptor 4 Cytoplasmic Domain Provides a Specific Scaffold for the Recruitment of Signalling Adaptor Proteins , 2007, PloS one.

[108]  L. Golitz,et al.  Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. , 2004, Journal of the American Academy of Dermatology.

[109]  N. Gay,et al.  Two Human MYD88 Variants, S34Y and R98C, Interfere with MyD88-IRAK4-Myddosome Assembly , 2010, The Journal of Biological Chemistry.

[110]  N. Tsuchimori,et al.  TAK-242 (Resatorvid), a Small-Molecule Inhibitor of Toll-Like Receptor (TLR) 4 Signaling, Binds Selectively to TLR4 and Interferes with Interactions between TLR4 and Its Adaptor Molecules , 2011, Molecular Pharmacology.

[111]  F. Granucci,et al.  CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4 , 2011, Cell.

[112]  Michael J Rust,et al.  Sub-diffraction-limit imaging by stochastic optical reconstruction microscopy (STORM) , 2006, Nature Methods.